» Articles » PMID: 11123937

Phospholipid Transfer is a Prerequisite for PLTP-mediated HDL Conversion

Overview
Journal Biochemistry
Specialty Biochemistry
Date 2000 Dec 22
PMID 11123937
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Phospholipid transfer protein (PLTP) is an important regulator of high-density lipoprotein (HDL) metabolism. The two main functions of PLTP are transfer of phospholipids between lipoprotein particles and modulation of HDL size and composition in a process called HDL conversion. These PLTP-mediated processes are physiologically important in the transfer of surface remnants from lipolyzed triglyceride-rich lipoproteins to nascent HDL particles and in the generation of prebeta-HDL, the initial acceptor of excess peripheral cell cholesterol. The aim of the study presented here was to investigate the interrelationship between the two functions of PLTP. Plasma PLTP was chemically modified using diethylpyrocarbonate or ethylmercurithiosalicylate. The modified proteins displayed a dose-dependent decrease in phospholipid transfer activity and a parallel decrease in the ability to cause HDL conversion. Two recombinant PLTP mutant proteins, defective in phospholipid transfer activity due to a mutation in the N-terminal lipid-binding pocket, were produced, isolated, and incubated together with radioactively labeled HDL(3). HDL conversion was analyzed using three methods: native gradient gel electrophoresis, ultracentrifugation, and crossed immunoelectrophoresis. The results demonstrate that the mutant proteins (i) are able to induce only a modest increase in HDL particle size compared to the wild-type protein, (ii) are unable to release apoA-I from HDL(3), and (iii) do not generate prebeta-mobile particles following incubation with HDL(3). These data suggest that phospholipid transfer is a prerequisite for HDL conversion and demonstrate the close interrelationship between the two main activities of PLTP.

Citing Articles

Loss-of-function mutation in Pcsk1 increases serum APOA1 level and LCAT activity in mice.

Aljakna Khan A, Kim N, Korstanje R, Choi S Lab Anim Res. 2022; 38(1):1.

PMID: 34996527 PMC: 8739671. DOI: 10.1186/s42826-021-00111-2.


The Role of Phospholipid Transfer Protein in the Development of Atherosclerosis.

Jiang X, Yu Y Curr Atheroscler Rep. 2021; 23(3):9.

PMID: 33496859 PMC: 8006745. DOI: 10.1007/s11883-021-00907-6.


Impact of Phospholipid Transfer Protein in Lipid Metabolism and Cardiovascular Diseases.

Jiang X Adv Exp Med Biol. 2020; 1276:1-13.

PMID: 32705590 PMC: 8025695. DOI: 10.1007/978-981-15-6082-8_1.


ApoE and apoC-III-defined HDL subtypes: a descriptive study of their lecithin cholesterol acyl transferase and cholesteryl ester transfer protein content and activity.

Amaya-Montoya M, Pinzon-Cortes J, Silva-Bermudez L, Ruiz-Manco D, Perez-Matos M, Jimenez-Mora M Lipids Health Dis. 2020; 19(1):106.

PMID: 32450892 PMC: 7249299. DOI: 10.1186/s12944-020-01291-x.


Prodomain of Furin Promotes Phospholipid Transfer Protein Proteasomal Degradation in Hepatocytes.

Yu Y, Lei X, Jiang H, Li Z, Creemers J, Zhang M J Am Heart Assoc. 2018; 7(9).

PMID: 29680823 PMC: 6015287. DOI: 10.1161/JAHA.118.008526.